Intrathecal baclofen therapy does not prevent hip displacement in children with cerebral palsy

This letter to the editor is on the commentary by Gormley on pages 1003–1004 of this issue.

Saved in:
Bibliographic Details
Published inDevelopmental medicine and child neurology Vol. 65; no. 8; p. 1124
Main Authors Howard, Jason J., Shrader, M. Wade
Format Journal Article
LanguageEnglish
Published England 01.08.2023
Subjects
Baclofen - therapeutic use
Cerebral Palsy - complications
Cerebral Palsy - drug therapy
Child
Hip Dislocation
Humans
Infusion Pumps, Implantable
Injections, Spinal
Muscle Relaxants, Central - therapeutic use
Muscle Spasticity - drug therapy
Muscle Spasticity - etiology
Online AccessGet full text

Cover

More Information
Summary:This letter to the editor is on the commentary by Gormley on pages 1003–1004 of this issue.
Bibliography:of this issue.
This letter to the editor is on the commentary by Gormley on pages
1003–1004
SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Commentary-2
ISSN:0012-1622
1469-8749
DOI:10.1111/dmcn.15641